X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (210) 210
male (136) 136
angiocentric lymphoma (129) 129
female (129) 129
middle aged (116) 116
adult (104) 104
aged (88) 88
angiocentric immunoproliferative lesions (81) 81
pathology (80) 80
epstein-barr-virus (72) 72
oncology (72) 72
epstein-barr virus (66) 66
immunohistochemistry (54) 54
t-cell lymphoma (54) 54
index medicus (52) 52
lymphomatoid granulomatosis (52) 52
lymphoma, t-cell - pathology (50) 50
chemotherapy (45) 45
hematology (44) 44
lethal midline granuloma (44) 44
adolescent (43) 43
treatment outcome (41) 41
polymorphic reticulosis (40) 40
radiotherapy (40) 40
diagnosis, differential (38) 38
non-hodgkins-lymphoma (38) 38
nose neoplasms - pathology (38) 38
prognosis (37) 37
in situ hybridization (34) 34
herpesvirus 4, human - isolation & purification (33) 33
immunophenotyping (33) 33
killer cells, natural - pathology (33) 33
non-hodgkins-lymphomas (32) 32
lymphomas (31) 31
lymphomatoid granulomatosis - pathology (31) 31
t-cell (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
lymphoma (30) 30
skin neoplasms - pathology (30) 30
spectrum (29) 29
t cells (26) 26
surgery (25) 25
aged, 80 and over (24) 24
combined modality therapy (24) 24
hemophagocytic syndrome (23) 23
lymphoma - pathology (23) 23
classification (22) 22
disease-free survival (22) 22
prognostic-factors (22) 22
retrospective studies (22) 22
neoplasm staging (21) 21
angiocentric immunoproliferative lesion (20) 20
angiocentric t-cell (20) 20
expression (20) 20
nose neoplasms - radiotherapy (20) 20
angiocentric (19) 19
child (19) 19
disease (19) 19
nose neoplasms - drug therapy (19) 19
cd56 (18) 18
diagnosis (18) 18
fatal outcome (18) 18
herpesvirus 4, human - genetics (18) 18
nose neoplasms - mortality (18) 18
skin (18) 18
cancer (17) 17
dermatology & venereal diseases (17) 17
killer cells, natural (17) 17
lymphoma, extranodal nk-t-cell - pathology (17) 17
non-hodgkin's lymphomas (17) 17
nose (17) 17
survival rate (17) 17
upper aerodigestive tract (17) 17
viral-dna (17) 17
angiocentric t-cell lymphoma (16) 16
dermatology (16) 16
lymphoma, extranodal nk-t-cell - mortality (16) 16
lymphoma, t-cell - immunology (16) 16
antigens, cd - analysis (15) 15
involvement (15) 15
lymphoma, extranodal nk-t-cell - radiotherapy (15) 15
lymphoma, t-cell, cutaneous - pathology (15) 15
lymphomatoid granulomatosis - diagnosis (15) 15
nk/t-cell lymphoma (15) 15
radiation-therapy (15) 15
biopsy (14) 14
infection (14) 14
lymphoma, t-cell - drug therapy (14) 14
nasal cavity (14) 14
polymerase chain-reaction (14) 14
rna, viral - analysis (14) 14
young adult (14) 14
care and treatment (13) 13
child, preschool (13) 13
clinicopathological features (13) 13
lung neoplasms - pathology (13) 13
lymphoproliferative disorders (13) 13
malignant-lymphoma (13) 13
malignant-lymphomas (13) 13
nasal lymphoma (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 06/1997, Volume 89, Issue 12, pp. 4501 - 4513
Expression of the natural killer (NK) cell antigen CD56 is uncommon among lymphomas, and those that do are almost exclusively of non-B-cell lineage and show a... 
K MA HEMATOLOGY | LARGE GRANULAR LYMPHOCYTES | MALIGNANT-LYMPHOMA | POLYMORPHIC RETICULOSIS | LYMPHOPROLIFERATIVE DISORDER | ANGIOCENTRIC IMMUNOPROLIFERATIVE LESIONS | UPPER AERODIGESTIVE TRACT | T-CELL | PROLIFERATIVE DISORDERS | HEMATOLOGY | CLONAL PROLIFERATION | EPSTEIN-BARR-VIRUS | Precursor Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Humans | Middle Aged | Infant | Male | Life Tables | Lymphoma, Non-Hodgkin - pathology | Herpesvirus 4, Human - isolation & purification | Lymphoma, T-Cell - virology | Adult | Female | Lymphoma, T-Cell, Peripheral - classification | Herpesvirus 4, Human - pathogenicity | Retrospective Studies | Antigens, Neoplasm - analysis | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Tumor Virus Infections - epidemiology | Child | Lymphoma, Non-Hodgkin - classification | Lymphoma, T-Cell - epidemiology | Lymphoma, T-Cell, Peripheral - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Lymphoma, Non-Hodgkin - virology | CD56 Antigen - analysis | Immunophenotyping | Lymphoma, Non-Hodgkin - epidemiology | Organ Specificity | Disease Progression | Lymphoma, Large B-Cell, Diffuse - mortality | Hong Kong - epidemiology | Lymphoma, Large B-Cell, Diffuse - classification | Lymphoma, T-Cell, Peripheral - pathology | Adolescent | Lymphoma, T-Cell - pathology | Survival Analysis | Aged | Precursor Cell Lymphoblastic Leukemia-Lymphoma - virology | Killer Cells, Natural - chemistry | Lymphoma, T-Cell - classification | Lymphoma, T-Cell, Peripheral - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - classification | Herpesviridae Infections - epidemiology
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 08/2011, Volume 35, Issue 8, pp. 1195 - 1203
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 6027 - 6032
Journal Article
CD-3 positive extranodal T-cell lymphoma of nasal type with skin involvement, 12/2006
A 40-year-old previously healthy lady presented with nasal obstruction and localized plaques over the right arm. She developed complete nasal obstruction due... 
Angiocentric lymphoma, CD-3 positive, Extranodal T-cell lymphoma
Journal
Head & Neck, ISSN 1043-3074, 07/2004, Volume 26, Issue 7, pp. 584 - 593
Background. The purpose of this study was to investigate the clinical relevance of subtypes categorized by immunophenotypic analysis in primary sinonasal... 
prognostic factor | NK/T‐cell lymphomas | immunophenotype | sinonasal lymphomas | Prognostic factor | NK/T-cell lymphomas | Sinonasal lymphomas | Immunophenotype | NASOPHARYNX | SURGERY | ANGIOCENTRIC LYMPHOMA | PROGNOSTIC-FACTORS | PARANASAL SINUSES | NON-HODGKINS-LYMPHOMAS | CLASSIFICATION | OTORHINOLARYNGOLOGY | T-CELL LYMPHOMAS | NASAL CAVITY | RESISTANCE | EPSTEIN-BARR-VIRUS | Killer Cells, Natural | Prognosis | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Paranasal Sinus Neoplasms - classification | Lymphoma, T-Cell - metabolism | Treatment Failure | Adult | Female | Retrospective Studies | Paranasal Sinus Neoplasms - therapy | CD56 Antigen - metabolism | Lymphoma, B-Cell - metabolism | Lymphoma, B-Cell - mortality | Immunophenotyping | Lymphoma, T-Cell - microbiology | Antigens, CD20 - metabolism | Lymphoma, B-Cell - classification | Paranasal Sinus Neoplasms - mortality | Lymphoma, T-Cell - therapy | Paranasal Sinus Neoplasms - metabolism | Adolescent | Survival Analysis | Aged | Lymphoma, T-Cell - mortality | Lymphoma, T-Cell - classification | Head | Cell survival | Data processing | Gastrointestinal tract | Lymphocytes T | Multivariate analysis | Non-Hodgkin's lymphoma | Lymph nodes | Hemophagocytic syndrome | Lymphocytes B | Sinus | Nose | Remission | Diaphragm | Neck | Testes | Skin tests | T-cell lymphoma | B-cell lymphoma
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2013, Volume 26, Issue 1, pp. 15 - 21
Epstein–Barr virus (EBV)-associated natural killer (NK)/T-cell lymphomas show a geographical predilection for Asian and South American populations and are rare... 
Hematology, Oncology and Palliative Medicine | PTCL-NOS | nasal type (ENKL) | cytotoxic molecules | Epstein–Barr virus (EBV) | extranodal NK/T-cell lymphoma | extranodal NK/T-cell lymphoma nasal type (ENKL) PTCL-NOS Epstein-Barr virus (EBV) cytotoxic molecules | L-ASPARAGINASE | ANGIOCENTRIC LYMPHOMA | PROGNOSTIC-FACTORS | NEOPLASMS | TRANSPLANTATION | THERAPY | NASAL-TYPE | LEUKEMIA | RADIOTHERAPY | Epstein-Barr virus (EBV) | HEMATOLOGY | EXPRESSION | Natural Killer T-Cells - drug effects | Perforin - genetics | Granzymes - metabolism | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Gamma Rays - therapeutic use | Herpesvirus 4, Human - drug effects | Antineoplastic Agents - therapeutic use | Granzymes - genetics | Lymphoma, Extranodal NK-T-Cell - virology | Lymphoma, Extranodal NK-T-Cell - therapy | Epstein-Barr Virus Infections - therapy | Natural Killer T-Cells - pathology | Asparaginase - therapeutic use | Biomarkers - metabolism | Epstein-Barr Virus Infections - virology | Lymphoma, T-Cell, Peripheral - virology | Herpesvirus 4, Human - physiology | Antineoplastic Combined Chemotherapy Protocols | Hematopoietic Stem Cell Transplantation | Epstein-Barr Virus Infections - pathology | Lymphoma, T-Cell, Peripheral - diagnosis | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Lymphoma, Extranodal NK-T-Cell - pathology | Lymphoma, T-Cell, Peripheral - pathology | Epstein-Barr Virus Infections - diagnosis | Lymphoma, T-Cell, Peripheral - therapy | Perforin - metabolism | Lymphoma, Extranodal NK-T-Cell - diagnosis | Natural Killer T-Cells - virology | Virus diseases | Chemotherapy | Anthracyclines | Etoposide | Epstein-Barr virus | Non-Hodgkin's lymphomas | Methotrexate | T cells | Cancer
Journal Article
Cancer, ISSN 0008-543X, 07/2012, Volume 118, Issue 13, pp. 3294 - 3301
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1809 - 1815
Purpose This study aims to evaluate the outcome and pattern of failure in a large cohort of patients with Stage I NK/T-cell lymphoma of the upper aerodigestive... 
Radiology | Hematology, Oncology and Palliative Medicine | Stage I | NK/T-cell lymphoma | Prognosis | Radiotherapy | WALDEYER RING | POLYMORPHIC RETICULOSIS | INITIAL TREATMENT | UPPER AERODIGESTIVE TRACT | CHEMOTHERAPY | ANGIOCENTRIC T-CELL | ONCOLOGY | INTERNATIONAL PROGNOSTIC INDEX | NATURAL KILLER/T-CELL | RADIATION TREATMENT | NON-HODGKINS-LYMPHOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Recurrence | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Oropharyngeal Neoplasms - pathology | Young Adult | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Nose Neoplasms - radiotherapy | Adult | Female | Mouth Neoplasms - radiotherapy | Radiotherapy Dosage | Nose Neoplasms - pathology | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Mouth Neoplasms - mortality | Remission Induction | Disease Progression | Disease-Free Survival | Lymphoid Tissue - pathology | Lymphoma, Extranodal NK-T-Cell - pathology | Adolescent | Lymphoma, Extranodal NK-T-Cell - mortality | Mouth Neoplasms - pathology | Aged | Neoplasm Staging | Nose Neoplasms - mortality | Care and treatment | Nuclear radiation | Lymphomas | Non-Hodgkin's lymphomas | T cells | Tumors | Cancer | Oral cavity | Integration | Nose | Survival | Lymph nodes | T-cell lymphoma | LYMPHOMAS | DIAGNOSIS | PATIENTS | ORAL CAVITY | LYMPH NODES | FAILURES | NOSE | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | RADIOTHERAPY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5594 - 5600
Journal Article